[Treatment of hypertension in elderly patients with coronary heart disease]

Nihon Rinsho. 2005 Jun;63(6):1033-9.
[Article in Japanese]

Abstract

Many clinical trials have been conducted to prevent cardiovascular complications and reduce mortality in hypertensive patients. Undoubted, but limited effects of beta-blocker and diuretic antihypertensive drugs had been established. Although angiotensin-converting enzyme inhibitor and angiotensin II receptor antagonist lowered the incidence of events and mortality less than classical antihypertensive drugs, recent studies revealed that prompt and enough lowering the blood pressure is more important than choosing the types of drugs.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Aged
  • Amlodipine / therapeutic use
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Calcium Channel Blockers / therapeutic use
  • Coronary Disease / drug therapy*
  • Coronary Disease / etiology*
  • Coronary Disease / prevention & control
  • Diuretics / therapeutic use
  • Double-Blind Method
  • Drug Therapy, Combination
  • Enalapril / therapeutic use
  • Humans
  • Hypertension / complications*
  • Hypertension / drug therapy*
  • Losartan / therapeutic use
  • Randomized Controlled Trials as Topic*
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Calcium Channel Blockers
  • Diuretics
  • Amlodipine
  • Enalapril
  • Losartan